「cta」の検索結果

Liquid Glass material best practices for SwiftUI, UIKit, and AppKit on iOS 26+/macOS 26+ (Tahoe) through iOS 27/macOS 27. Use when implementing, reviewing, or migrating to glass: glassEffect, Glass variants (.regular/.clear/.identity), tint, interactive(), GlassEffectContainer, glassEffectUnion, toolbar glass, ToolbarSpacer, scrollEdgeEffectStyle, sharedBackgroundVisibility, tabBarMinimizeBehavior, backgroundExtensionEffect, NSGlassEffectView, UIGlassEffect, Tahoe window chrome, glass accessibility (Reduce Transparency/Increase Contrast), pre-26 Material fallbacks, UIDesignRequiresCompatibility. Also fires on symptoms: glass renders dark or muddy, glass looks like a flat tinted rectangle, glass button doesn't register taps, tap passes through glass, "'glassEffect' is only available in iOS 26.0 or newer", "ambiguous use of 'opacity'", "'cornerRadius' was deprecated", glass looks different in simulator vs device, screenshots of glass UI don't match. For glass animation, morphing, glassEffectID, transitions, Metal shaders, or performance profiling use the liquid-glass-motion skill instead.

日本語の概要は準備中です。原文の説明を表示しています。

When isolating and fixing unpredictable or complex software bugs.

日本語の概要は準備中です。原文の説明を表示しています。

Diagnose, fix, or validate SwiftUI animation and scroll behavior by temporarily instrumenting views with MotionEyes, capturing console traces over time, and comparing motion data to user intent or test expectations. Use when users report bugs such as wrong direction, premature fade, timing or easing mismatch, unexpected movement, missing movement, incorrect relative movement between views, scroll jumps, scroll restoration drift, content-offset desynchronization, or when they want to turn MotionEyes traces into focused assertions. Prefer XcodeBuildMCP log capture first and fallback to CLI log streaming; remove only agent-added MotionEyes instrumentation after validation.

日本語の概要は準備中です。原文の説明を表示しています。

Trading strategy builder for coding agents. Use when Codex, Claude, Cursor, or a SKILL.md host needs to turn a trading idea into market Evidence, an inspectable Signal, a private Replay, Replay status, or an opt-in Studio Publication. Stingray does not place trades.

日本語の概要は準備中です。原文の説明を表示しています。

Guides systematic root-cause debugging. Use when tests fail, builds break, behavior doesn't match expectations, or you encounter any unexpected error. Use when you need a systematic approach to finding and fixing the root cause rather than guessing.

日本語の概要は準備中です。原文の説明を表示しています。

Ingeniero de Sistemas de Andru.ia. Diseña, redacta y despliega nuevas habilidades (skills) dentro del repositorio siguiendo el Estándar de Diamante.

日本語の概要は準備中です。原文の説明を表示しています。

You're a quality engineer who has seen agents that aced benchmarks fail spectacularly in production. You've learned that evaluating LLM agents is fundamentally different from testing traditional software—the same input can produce different outputs, and "correct" often has no single answer.

日本語の概要は準備中です。原文の説明を表示しています。

Estratega de Inteligencia de Dominio de Andru.ia. Analiza el nicho específico de un proyecto para inyectar conocimientos, regulaciones y estándares únicos del sector. Actívalo tras definir el nicho.

日本語の概要は準備中です。原文の説明を表示しています。

Finish an existing Japanese business talking-head, lecture, interview, or testimonial rough cut as a credibility-first vertical social video. Use when the user wants an SNS short that preserves the speaker's meaning while tightening repeated ideas, adding a first-second thesis, readable full captions, restrained punch-ins, speaker identification, a registered CTA card, dialogue-first audio, and retention QA.

日本語の概要は準備中です。原文の説明を表示しています。

Reference for writing and editing skills well — the vocabulary and principles that make a skill predictable.

日本語の概要は準備中です。原文の説明を表示しています。

Write marketing copy for landing pages, product descriptions, CTAs, emails, and app UI text.

日本語の概要は準備中です。原文の説明を表示しています。

Quantitative drug-target validation pipeline. Scores druggability, selectivity, safety profile, ADMET feasibility, and structural tractability with a composite Target Validation Score (0-100) and GO/NO-GO recommendation. Use for go/no-go decisions on a target before commit-to-medchem, target prioritization across a list, and target-deselection rationale.

日本語の概要は準備中です。原文の説明を表示しています。

When the user wants to write, rewrite, or improve marketing copy for any page — including homepage, landing pages, pricing pages, feature pages, about pages, or product pages. Also use when the user says "write copy for," "improve this copy," "rewrite this page," "marketing copy," "headline help," or "CTA copy." For email copy, see email-sequence. For popup copy, see popup-cro.

日本語の概要は準備中です。原文の説明を表示しています。

Creates and edits CARLA Leaderboard route files — placing waypoints and scenario trigger points interactively from the spectator camera (route_creator, scenario_creator), visualising an existing route in the simulator (route_displayer), summarising it as a table (route_summarizer), capturing the current weather in route format (weather_creator), sorting scenarios by route position (scenario_orderer) and converting 1.0-format routes to 2.x (route_bridge). Use when the user asks to "make a new route", "add a scenario to a route", "visualise/debug a route", "see what's in this route file", or "convert old leaderboard routes".

日本語の概要は準備中です。原文の説明を表示しています。

Taxonomia de 86 layouts de apresentação/marketing (hero, pricing, auth, nav, CTA, testimonials, footer, FAQ, onboarding, blog, contact, stats, bento, states) adaptada do VibeUI. Consultar ANTES de construir landing pages, onboarding flows, auth screens, ou qualquer UI de camada de apresentação. Complementa o design-library/solutions (que cobre módulos verticais de produto).

日本語の概要は準備中です。原文の説明を表示しています。

Quality review ads before launch by verifying hook strength, checking proof elements, evaluating CTA effectiveness, and assessing visual quality and authenticity. Use as final check before launching creative or when reviewing team submissions.

日本語の概要は準備中です。原文の説明を表示しています。

Plan the first months at a new Japanese employer after an offer is accepted, listing every expectation and promise made in interviews, the offer, or negotiation with its source, separating what is in writing from what was only said and what has no agreed measure, working out when the probation period ends and whether its criteria and conditions are known, and scheduling who to confirm what with before and after the start date. Use when a user has accepted an offer and wants to prepare for joining, make sure verbal promises such as remote days or a future role are confirmed, or understand what the probation period means for them; do not use to predict whether they will fit in or pass probation, to judge their manager or colleagues, to rule on the legality of probation terms, or to contact the new employer.

日本語の概要は準備中です。原文の説明を表示しています。

Debrief a finished Otameshi Tenshoku trial from the employer's side: set the observed facts against the completion criteria agreed before the start, keep expectations added afterwards, second-hand or off-the-job observations and the company's own late or missing support apart, settle the hours actually worked separately from any evaluation, and draft feedback to the candidate that states facts, support gaps and what happens next without promising a hire or continuation the company has not decided. Use when a hiring manager, recruiter or small-business owner wants to review a trial, decide what to tell the candidate, or work out the settlement after a shortfall; do not use to judge the candidate's aptitude or predict a hire, to cut pay or demand unpaid rework because of dissatisfaction, to compare candidates, or to send the feedback, pay, or update records on the user's behalf.

日本語の概要は準備中です。原文の説明を表示しています。

Profiles a genome from raw reads BEFORE assembly with a k-mer spectrum (KMC or Jellyfish histogram), then models it with GenomeScope2 to estimate genome size, heterozygosity, repeat content, and ploidy, and Smudgeplot to infer ploidy from heterozygous k-mer pairs (diploid AB vs triploid AAB vs tetraploid AABB). Covers choosing k via Merqury best_k.sh, the k-mer-coverage vs sequencing-coverage confusion, reading het/repeat/contamination/organelle peaks, why noisy ONT must not be used for counting, and how the estimate becomes the NG50 denominator, the Flye -g value, the hifiasm --hom-cov/purge setting, and the 1.5-2x-too-big haplotig sanity check. Use when starting any de novo assembly, deciding whether short reads can work, estimating genome size for an unknown organism, diagnosing ploidy, or sanity-checking an assembly's size against expectation.

日本語の概要は準備中です。原文の説明を表示しています。

Defines cell populations in flow and spectral cytometry through manual gates (rectangle, polygon, quadrant, boolean) and reproducible automated gating (openCyto gating templates, flowDensity data-driven thresholds, flowClust model-based gates), organized as a hierarchical GatingSet (flowWorkspace) and round-tripped with FlowJo via CytoML. Covers the canonical gate order (time -> debris -> singlets -> live -> lineage), FMO-vs-isotype boundary setting, gate-order dependence and recompute semantics, rare-event/MRD gating, and per-population statistics. Use when building a gating strategy, automating a manual FlowJo scheme across samples, choosing manual vs data-driven gates, or extracting population frequencies.

日本語の概要は準備中です。原文の説明を表示しています。

Corrects the gene-independent copy-number artifact in CRISPR-Cas9 screens (Aguirre 2016 / Munoz 2016 Cancer Discov) where amplified loci appear essential from DNA-damage burden of simultaneous cuts. Covers the p53-dependent G2-arrest mechanism, CRISPRcleanR (Iorio 2018) unsupervised pre-hoc correction, CERES (Meyers 2017) joint CN + gene-effect model, Chronos (Dempster 2021) DepMap-standard population-dynamics + CN model with lowest residual bias, the decision tree by data availability, the Spearman LFC-vs-CN diagnostic, focal-amplification examples (ERBB2 in HER2+, MYC in colorectal, FGFR1 in head and neck), and CRISPRi/a alternatives that bypass the artifact. Use when screening cancer cell lines, diagnosing essentiality at amplified loci, choosing CRISPRcleanR / CERES / Chronos, deciding whether CN correction is needed before MAGeCK / BAGEL2 / drugZ, or switching from Cas9 to CRISPRi.

日本語の概要は準備中です。原文の説明を表示しています。

Estimate SNP heritability and partition it across functional annotations, cell types, and loci from GWAS summary statistics or individual-level genotypes. Implements LDSC, stratified LDSC with the baseline-LD model, Finucane 2018 cell-type prioritization, LDAK SumHer, HDL, HESS local heritability, BOLT-REML, GCTA-GREML, graphREML, and Popcorn cross-population genetic correlation. Use when computing total h2_SNP from summary stats, partitioning heritability across functional categories, prioritizing trait-relevant tissues or cell types from ENCODE/Roadmap chromatin marks, reconciling LDSC vs LDAK enrichment estimates, computing local heritability with HESS, estimating genetic correlation between traits, or producing publication-grade enrichment with calibrated sensitivity to model assumptions.

日本語の概要は準備中です。原文の説明を表示しています。

Genera tickets profesionales de soporte para Meta Business Suite / WhatsApp Business API optimizados para recibir prioridad URGENTE 24hr resolution. Úsala SIEMPRE que el usuario mencione crear un ticket a Meta, escalar un caso WABA, apelar un ban o restricción, reportar un false positive, abrir caso de soporte WhatsApp Business, problema de onboarding, rechazo de template, errores de Cloud API, OTP delivery, verification stuck, BM restricted, display name rejection, o cualquier issue de una WhatsApp Business Account. También activa cuando el usuario dice frases como "ayúdame a redactar un caso para Meta", "necesito reportar esto a soporte", "hay que escalar esto a WhatsApp", "ticket para Meta", o describe un problema de una cuenta de cliente de Vambe sin pedir ticket explícitamente pero claramente necesita uno. También activa ante preguntas del tipo "¿cómo apelar esto?" o "¿qué hago si Meta dice X?" relacionadas con WABA, BM o verificación.

日本語の概要は準備中です。原文の説明を表示しています。

Estratega de Inteligencia de Dominio de Andru.ia. Analiza el nicho específico de un proyecto para inyectar conocimientos, regulaciones y estándares únicos del sector. Actívalo tras definir el nicho.

日本語の概要は準備中です。原文の説明を表示しています。